Experiences of Screening for Human Immunodeficiency Virus, Viral Hepatitis B, and Viral Hepatitis C Infections at a Hospital in Thailand: Test Utilization and Outcomes
- PMID: 31597908
- PMCID: PMC6802465
- DOI: 10.12659/MSMBR.918374
Experiences of Screening for Human Immunodeficiency Virus, Viral Hepatitis B, and Viral Hepatitis C Infections at a Hospital in Thailand: Test Utilization and Outcomes
Abstract
BACKGROUND To prevent the transmission of HIV and hepatitis B and C viruses, early detection is necessary; however, in the early stage, most infected people are symptomless. Screening for these infections should be targeted to certain clinical settings to increase the early detection rate. MATERIAL AND METHODS This retrospective study was conducted by analyzing data from patients' medical records to determine how the screening tests for these viral infections were utilized and what the clinical outcomes from the test utilization were. RESULTS From 11 676 collected records, the screening tests for HIV, HBV, and HCV infections were utilized in 871, 556, and 236 cases, respectively. The tests for HIV and HCV were utilized the most in people with chronic non-infectious diseases, while the test for HBV infection was utilized the most in pregnant women. The positive results of these tests were highly found in the group of patients with acute non-infectious diseases. HIV infection was newly detected in 1.38% of patients, and HBV and HCV infections were newly detected in 5.58% and 2.12%, respectively. CONCLUSIONS Screening for HIV and HBV infections was performed according to the guidelines of the national HIV and HBV programs. The Outpatient Department (OPD) and medical ward may be the most appropriate clinical settings for HIV screening because most patients are there and blood tests are often ordered there, too. The national programs helped slow the rates of HIV and HBV infections in this community.
Figures
Similar articles
-
Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.S Afr Med J. 2013 Jan 24;103(3):186-8. doi: 10.7196/samj.6097. S Afr Med J. 2013. PMID: 23472697
-
2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.Liver Int. 2016 Oct;36(10):1442-9. doi: 10.1111/liv.13135. Epub 2016 May 1. Liver Int. 2016. PMID: 27043826
-
Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.Clin Microbiol Infect. 2013 Dec;19(12):E533-41. doi: 10.1111/1469-0691.12292. Epub 2013 Jul 31. Clin Microbiol Infect. 2013. PMID: 23902574
-
Mini review: current molecular methods for the detection and quantification of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1.Int J Infect Dis. 2014 Aug;25:145-9. doi: 10.1016/j.ijid.2014.04.007. Epub 2014 Jun 10. Int J Infect Dis. 2014. PMID: 24927665 Review.
-
Deceased tissue donor serology and molecular testing for HIV, hepatitis B and hepatitis C viruses: a lack of cadaveric validated tests.Cell Tissue Bank. 2016 Dec;17(4):543-553. doi: 10.1007/s10561-016-9564-7. Epub 2016 Jun 21. Cell Tissue Bank. 2016. PMID: 27329292 Review.
Cited by
-
Prevalence of Hepatitis B and C Virus Infections: Influence of National Health Care Policies and Local Clinical Practices.Med Sci Monit Basic Res. 2021 Nov 1;27:e933692. doi: 10.12659/MSMBR.933692. Med Sci Monit Basic Res. 2021. PMID: 34719666 Free PMC article.
References
-
- Deuffic-Burban S, Delarocque-Astagneau E, Abiteboul D, et al. Blood-borne viruses in health care workers: Prevention and management. J Clin Virol. 2011;52(1):4–10. - PubMed
-
- Leroi C, Adam P, Khamduang W, et al. Prevalence of chronic hepatitis B virus infection in Thailand: A systematic review and meta-analysis. Int J Infect Dis. 2016;51:36–43. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical